KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Debt Ratio (2016 - 2026)

Pacira BioSciences has reported Debt Ratio over the past 15 years, most recently at 0.3 for Q1 2026.

  • For Q1 2026, Debt Ratio rose 59.0% year-over-year to 0.3; the TTM value through Mar 2026 reached 0.3, up 59.0%, while the annual FY2025 figure was 0.29, 21.91% down from the prior year.
  • Debt Ratio for Q1 2026 was 0.3 at Pacira BioSciences, up from 0.29 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.38 in Q4 2024 and troughed at 0.07 in Q2 2024.
  • A 5-year average of 0.18 and a median of 0.19 in 2022 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: tumbled 61.21% in 2023 and later surged 378.98% in 2024.
  • Year by year, Debt Ratio stood at 0.17 in 2022, then plummeted by 53.55% to 0.08 in 2023, then surged by 378.98% to 0.38 in 2024, then dropped by 21.91% to 0.29 in 2025, then grew by 3.39% to 0.3 in 2026.
  • Business Quant data shows Debt Ratio for PCRX at 0.3 in Q1 2026, 0.29 in Q4 2025, and 0.29 in Q3 2025.